You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Digoxin and Mortality in Patients With Atrial Fibrillation
|
|---|---|
| Published in |
JACC, March 2018
|
| DOI | 10.1016/j.jacc.2017.12.060 |
| Pubmed ID | |
| Authors |
Renato D. Lopes, Roberto Rordorf, Gaetano M. De Ferrari, Sergio Leonardi, Laine Thomas, Daniel M. Wojdyla, Peter Ridefelt, John H. Lawrence, Raffaele De Caterina, Dragos Vinereanu, Michael Hanna, Greg Flaker, Sana M. Al-Khatib, Stefan H. Hohnloser, John H. Alexander, Christopher B. Granger, Lars Wallentin, ARISTOTLE Committees and Investigators |
| Abstract |
Digoxin is widely used in patients with atrial fibrillation (AF). The goal of this paper was to explore whether digoxin use was independently associated with increased mortality in patients with AF and if the association was modified by heart failure and/or serum digoxin concentration. The association between digoxin use and mortality was assessed in 17,897 patients by using a propensity score-adjusted analysis and in new digoxin users during the trial versus propensity score-matched control participants. The authors investigated the independent association between serum digoxin concentration and mortality after multivariable adjustment. At baseline, 5,824 (32.5%) patients were receiving digoxin. Baseline digoxin use was not associated with an increased risk of death (adjusted hazard ratio [HR]: 1.09; 95% confidence interval [CI]: 0.96 to 1.23; p = 0.19). However, patients with a serum digoxin concentration ≥1.2 ng/ml had a 56% increased hazard of mortality (adjusted HR: 1.56; 95% CI: 1.20 to 2.04) compared with those not on digoxin. When analyzed as a continuous variable, serum digoxin concentration was associated with a 19% higher adjusted hazard of death for each 0.5-ng/ml increase (p = 0.0010); these results were similar for patients with and without heart failure. Compared with propensity score-matched control participants, the risk of death (adjusted HR: 1.78; 95% CI: 1.37 to 2.31) and sudden death (adjusted HR: 2.14; 95% CI: 1.11 to 4.12) was significantly higher in new digoxin users. In patients with AF taking digoxin, the risk of death was independently related to serum digoxin concentration and was highest in patients with concentrations ≥1.2 ng/ml. Initiating digoxin was independently associated with higher mortality in patients with AF, regardless of heart failure. |
X Demographics
The data shown below were collected from the profiles of 598 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 133 | 22% |
| United States | 77 | 13% |
| Mexico | 23 | 4% |
| Venezuela, Bolivarian Republic of | 16 | 3% |
| United Kingdom | 13 | 2% |
| Argentina | 13 | 2% |
| Colombia | 12 | 2% |
| Chile | 10 | 2% |
| Ecuador | 7 | 1% |
| Other | 56 | 9% |
| Unknown | 238 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 459 | 77% |
| Practitioners (doctors, other healthcare professionals) | 79 | 13% |
| Scientists | 45 | 8% |
| Science communicators (journalists, bloggers, editors) | 14 | 2% |
| Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 252 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 252 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 27 | 11% |
| Student > Bachelor | 27 | 11% |
| Researcher | 23 | 9% |
| Student > Postgraduate | 22 | 9% |
| Student > Master | 19 | 8% |
| Other | 60 | 24% |
| Unknown | 74 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 108 | 43% |
| Pharmacology, Toxicology and Pharmaceutical Science | 25 | 10% |
| Nursing and Health Professions | 4 | 2% |
| Biochemistry, Genetics and Molecular Biology | 3 | 1% |
| Agricultural and Biological Sciences | 3 | 1% |
| Other | 16 | 6% |
| Unknown | 93 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 413. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 January 2023.
All research outputs
#73,174
of 25,918,061 outputs
Outputs from JACC
#172
of 17,006 outputs
Outputs of similar age
#1,777
of 347,715 outputs
Outputs of similar age from JACC
#4
of 414 outputs
Altmetric has tracked 25,918,061 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,006 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,715 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 414 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.